| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 04/23/2009 | WO2009050348A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 04/23/2009 | WO2009050197A2 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
| 04/23/2009 | WO2009049851A1 Spiroheterocyclic pyrrolidine dione derivatives useful as pesticides |
| 04/23/2009 | WO2009049479A1 Polymorphs of donepezil salts, preparation methods and uses thereof |
| 04/23/2009 | WO2009015164A3 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 04/23/2009 | WO2007044735A3 Amido-organoborate initiator systems |
| 04/23/2009 | US20090105310 Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds and Methods of Use |
| 04/23/2009 | US20090105305 Therapeutic Agents - 550 |
| 04/23/2009 | US20090105279 Tetrahydrofuro[2,3-b]furyl carbamates containing an (oxy)hydrazide group; these compounds target the HIV protease in both wild type and mutant strains of HIV. |
| 04/23/2009 | US20090105275 PIPERIDINYL AND PIPERAZINYL MODULATORS OF y-SECRETASE |
| 04/23/2009 | US20090105260 Molecules to Enhance Percutaneous Delivery and Methods for Discovery Therefor |
| 04/23/2009 | US20090105249 4-phenylsulfonamidopiperidines as calcium channel blockers |
| 04/23/2009 | CA2702950A1 Methods and compounds for modulating cannabinoid activity |
| 04/23/2009 | CA2702911A1 Gsm intermediates |
| 04/23/2009 | CA2702837A1 Piperidinyl and piperazinyl modulators of .gamma.-secretase |
| 04/23/2009 | CA2702445A1 Spiroheterocyclic pyrrolidine dione derivatives useful as pesticides |
| 04/23/2009 | CA2694994A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 04/22/2009 | EP2050450A1 1-Piperidine-2-cyanoimino-1,3-dihydro-2H-benzimidazole derivatives as nociceptin analogs with ORL1 modulating activity for the treatment of pain |
| 04/22/2009 | EP2049517A1 Amino-piperidine derivatives as cetp inhibitors |
| 04/22/2009 | EP2049486A2 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 04/22/2009 | EP2049473A2 Substituted benzyl amine compounds |
| 04/22/2009 | EP2049466A1 Butyl and butynyl benzyl amine compounds |
| 04/22/2009 | EP1507529B1 Combination comprising valsartan, amlodipine and hydrochlorothiazide |
| 04/22/2009 | CN101415673A Process for the preparation of an N-alkyl lactam with improved colour quality |
| 04/22/2009 | CN101415425A Triglyceride-lowering agent and hyperinsulinism-ameliorating agent |
| 04/22/2009 | CN101412703A Composite extracting technique for coproduction of mulberry tea flavone, polysaccharide and alkaloid |
| 04/22/2009 | CN101412693A 4-[1-hydroxy-1-(2,3-dimethoxyphenyl)methyl]piperidine and method for preparing corresponding piperidine thereby |
| 04/22/2009 | CN101412692A 1-(3-amino propyl) piperidine-4-aminoamide compounds, and pharmaceutical composition, preparation and use thereof |
| 04/21/2009 | US7521561 Biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenyl-carbamoyl)ethyl]piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, asthma |
| 04/21/2009 | US7521558 Crystalline form of a biphenyl compound |
| 04/21/2009 | US7521552 Process for preparation of substituted amino alcohols |
| 04/21/2009 | US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 04/21/2009 | US7521062 Thiosemicarbazones as anti-virals and immunopotentiators |
| 04/21/2009 | US7521041 Biphenyl-2-ylcarbamic acid or biphenyl-2-yluurea derivatives for treatment of respiratory system disorders; chronic obstructive pulmonary disease, asthma; antihistamines, bronchodilator agents; side effect reduction |
| 04/16/2009 | WO2009024823A3 Cyclopropyl amide derivatives |
| 04/16/2009 | WO2008010235A3 An improved process for the preparation of donepezil |
| 04/16/2009 | WO2007044084A3 Heterocyclic inhibitors of mek and methods of use thereof |
| 04/16/2009 | WO2003082205A3 Compounds and methods |
| 04/16/2009 | US20090099241 Pharmaceutical composition containing antihypertensive agents |
| 04/16/2009 | US20090099233 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
| 04/16/2009 | US20090099221 Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene-and furane-derivatives as kinase inhibitors |
| 04/16/2009 | US20090099186 Inhibitors of viral replication |
| 04/16/2009 | US20090099185 P38 Map Kinase Inhibitors |
| 04/16/2009 | US20090099139 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 04/15/2009 | EP2048132A1 Tetrahydro-naphthalene and urea derivatives |
| 04/15/2009 | EP2046745A1 Process for preparing amorphous lercanidipine hydrochloride |
| 04/15/2009 | EP2046744A2 Process for preparing fexofenadine |
| 04/15/2009 | EP2046743A1 Process for preparing fexofenadine |
| 04/15/2009 | EP2046739A1 Substituted aniline derivatives |
| 04/15/2009 | EP2046328A2 Pyridinone diketo acids: inhibitors of hiv replication in combination therapy |
| 04/15/2009 | EP1725235B1 Piperidine derivatives useful as ccr3 antagonists |
| 04/15/2009 | EP1720550B1 Derivatives of piperidinylalkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors |
| 04/15/2009 | CN101410374A Synthesis and preparations of intermediates and polymorphs thereof useful for the preparation of donepezil hydrochloride |
| 04/15/2009 | CN101407471A Compound capable of binding S1P receptor and pharmaceutical use thereof |
| 04/15/2009 | CN100478325C Preparation method for aminophenol compound |
| 04/15/2009 | CN100477992C Substituted piperazine and piperidine calcium channel blockers |
| 04/14/2009 | US7517994 Heterocyclic inhibitors of MEK and methods of use thereof |
| 04/14/2009 | US7517991 metabolic and eating disorders, improvement of cognitive function, substance abuse disorders, cognitive disorders, autoimmune glomerulonephritis |
| 04/14/2009 | US7517989 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/14/2009 | US7517988 N-hydroxy-4-[2-(benzofuran-2-ylcarbonylamino)ethylsulfonyl]-benzamide; hepatitis C; inhibitors of histone deacetylase |
| 04/14/2009 | US7517982 Naphthols useful for preparing indeno-fused photochromic naphthopyrans |
| 04/14/2009 | US7517910 Alkoxyphenylpropanoic acid derivatives |
| 04/14/2009 | US7517892 Ligands for monoamine receptors and transporters, and methods of use thereof |
| 04/14/2009 | CA2409841C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2408934C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2380980C Mutilin derivatives and their use as antibacterials |
| 04/14/2009 | CA2362914C Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
| 04/09/2009 | WO2009044404A1 Process for the preparation of (s)-ropivacaine hydrochloride monohydrate |
| 04/09/2009 | WO2009043747A2 N-heterocyclic biaryl carboxamides as ccr receptor antagonists |
| 04/09/2009 | WO2009043117A1 Novel aryl potassium channel blockers and uses thereof |
| 04/09/2009 | WO2009005647A3 Compounds and process to prepare chiral intermediates for synthesis of paroxetine |
| 04/09/2009 | WO2008145673A3 Method for the production of 4-formylaminopiperidine derivatives |
| 04/09/2009 | WO2008073623A3 Soluble epoxide hydrolase inhibitors |
| 04/09/2009 | WO2008055851A8 Process for the preparation of 2,5-bis-(2,2,2-trifluoroethoxy)-n-(2-piperidylmethyl)-benzamide and salts thereof |
| 04/09/2009 | WO2008050168A8 New sulfonamide derivatives as bradykinin antagonists |
| 04/09/2009 | WO2005086873A3 Novel m3 muscarinic acetylcholine receptor antagonists |
| 04/09/2009 | US20090093520 Plasma carboxypeptidase b inhibitors |
| 04/09/2009 | US20090093493 1-phenylalcoxy-2-beta-phenylethyl derivatives as p-glycoprotein (p-gp) inhibitors useful in drug resistance events |
| 04/09/2009 | US20090093479 Anti-cancer agents and uses thereof |
| 04/09/2009 | US20090093463 Novel compounds of substituted and unsubtituted adamantyl amides |
| 04/09/2009 | US20090093451 IL-8 Receptor Antagonists |
| 04/09/2009 | CA2701579A1 Novel aryl potassium channel blockers and uses thereof |
| 04/09/2009 | CA2700691A1 New biaryl derivatives |
| 04/08/2009 | EP2044022A1 (s)-(-)-amlodipine camsylate or hydrate thereof and pharmaceutical composition comprising same |
| 04/08/2009 | EP2044021A1 Process for preparing remifentanil, intermediates thereof, use of said intermediates and processes for their preparation |
| 04/08/2009 | EP2044020A1 Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain |
| 04/08/2009 | EP2044017A2 Substituted phenyl acetic acids as dp-2 antagonists |
| 04/08/2009 | EP1606251B1 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 04/08/2009 | EP1448566B3 Chemokine receptor antagonists and methods of use thereof |
| 04/08/2009 | EP1212299B1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 04/08/2009 | EP1179345B1 Inhibitors against increase in ocular tension caused by irradiation with lasers, containing 1,4-dihydropyridine derivatives |
| 04/08/2009 | CN101405266A Piperazines and piperidines as mGlur5 potentiators |
| 04/08/2009 | CN101405265A Amido compounds and their use as pharmaceuticals |
| 04/08/2009 | CN101405264A Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 04/08/2009 | CN101405263A Cannibinoid receptor modulators |
| 04/08/2009 | CN101402599A Bi(2,2,6,6-tetramethyl piperidine nitrogen oxygen free radical) ether ester and method of preparing the same |
| 04/08/2009 | CN100475778C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/08/2009 | CN100475206C Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 04/07/2009 | US7514564 Substituted amine derivatives and methods of use |
| 04/07/2009 | US7514563 Process for producing cyano substituted arene boranes and compounds |